Hikma Pharmaceuticals (HIK)

Sector: Pharma and Biotech     Index: FTSE 250
-0.56%
-6.00p
1,074.00p
17:00 15/12/17
1,074.00p
17:00 15/12/17
DAILY VARIATION
-0.56%
-6.00p
VOLUME
1,165,615
REAL TIME BATS
1,075.00p
16:30 15/12/17
-0.69%
-7.50p
DATA
52 Week High
2,297.00p
52 Week Low
949.50p
Shares Issued
240.66m
Market Cap
£2,584.71m
RiskGrade
204
Beta
1.15
MENU

Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 2.3% 2.1%
Div Cover 3.6 3.3
Op Mrgn 15.5% 14.1%
ROCE 19.3%
Latest F'cast
P/E 12.1 14.2
PEG -0.7 -0.8
Pr/Revenue 1.8 1.8
Pr/Book 1.4
Latest F'cast
Revenue 35.4% -19.3%
PBT -34.0% n/a
EPS -17.5% -39.3%
DPS 3.1% -4.5%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,109.00 132.00 61.40¢ 20.2 1.1 18% 16.00¢ 1.3%
2013-12-31 1,365.00 298.00 139.10¢ 14.3 0.1 127% 20.00¢ 1.0%
2014-12-31 1,489.00 362.00 151.00¢ 20.4 2.4 9% 22.00¢ 0.7%
2015-12-31 1,440.00 318.00 143.70¢ 23.6 -4.9 -5% 32.00¢ 0.9%
2016-12-31 1,950.00 210.00 118.50¢ 19.7 -1.1 -18% 33.00¢ 1.4%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 1,461.03 206.61 72.08p 14.2 -0.8 -19% 22.14p 2.2%
2018-12-31 1,482.67 208.84 72.88p 13.2 12.0 1% 22.95p 2.2%

Regulatory News

slide to see more
Holding(s) in Company 12-Dec-17 09:59
Holding(s) in Company 11-Dec-17 09:34
Total Voting Rights 01-Dec-17 09:30

Newspaper Links

No results found